Chemoinformaics analysis of 9-Dehydromanogenin
| Molecular Weight | 444.612 | nRot | 0 |
| Heavy Atom Molecular Weight | 404.292 | nRig | 31 |
| Exact Molecular Weight | 444.288 | nRing | 6 |
| Solubility: LogS | -4.517 | nHRing | 2 |
| Solubility: LogP | 3.802 | No. of Aliphatic Rings | 6 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 72 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 40 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 27 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 75.7717 |
| nHD | 2 | BPOL | 44.4683 |
| QED | 0.552 |
| Synth | 5.798 |
| Natural Product Likeliness | 3.361 |
| NR-PPAR-gamma | 0.139 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.643 |
| Pgp-sub | 0.995 |
| HIA | 0.012 |
| CACO-2 | -5.052 |
| MDCK | 0.00000679 |
| BBB | 0.569 |
| PPB | 0.738864 |
| VDSS | 1.778 |
| FU | 0.0875306 |
| CYP1A2-inh | 0.012 |
| CYP1A2-sub | 0.546 |
| CYP2c19-inh | 0.02 |
| CYP2c19-sub | 0.852 |
| CYP2c9-inh | 0.027 |
| CYP2c9-sub | 0.039 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.081 |
| CYP3a4-inh | 0.782 |
| CYP3a4-sub | 0.497 |
| CL | 15.805 |
| T12 | 0.418 |
| hERG | 0.468 |
| Ames | 0.176 |
| ROA | 0.695 |
| SkinSen | 0.932 |
| Carcinogencity | 0.671 |
| EI | 0.204 |
| Respiratory | 0.988 |
| NR-Aromatase | 0.537 |
| Antiviral | Yes |
| Prediction | 0.777497 |